Efficacy and safety of brexpiprazole (OPC-34712) as adjunctive treatment in major depressive disorder: Meta-analysis of two pivotal studies

被引：0
|
作者：
Eriksson, Hans [1 ]
Weiller, Emmanuelle [1 ]
Weiss, Catherine [2 ]
Zhang, Peter [2 ]
Skuban, Aleksandar [2 ]
Thase, Michael E. [3 ]
机构：
[1] H Lundbeck & Co AS, Valby, Denmark
[2] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[3] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2016年 / 19卷
关键词：
INADEQUATE RESPONSE; ANTIDEPRESSANTS; PHASE-3; MG;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS152
引用
收藏
页码：102 / 102
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Adjunctive Brexpiprazole (OPC-34712) in Major Depressive Disorder: Results: of Two Pivotal Clinical Studies
    Thase, Michael
    Youakim, James
    Skuban, Alexander
    Hobart, Mary
    Zhang, Peter
    Legacy, Susan
    McQuade, Robert
    Nyilas, Margaretta
    Carson, William
    Sanchez, Raymond
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S357 - S357
  • [2] Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies
    Correll, C.
    Skuban, A.
    Ouyang, J.
    Weiss, C.
    Weiller, E.
    Kane, J. M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S522 - S523
  • [3] Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies
    Skuban, Aleksandar
    Kane, John M.
    Ouyang, John
    Weiss, Catherine
    Weiller, Emmanuelle
    Correll, Christoph U.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 202 - 202
  • [4] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Irritability: An Exploratory Study
    Menard, Francois
    Fava, Maurizio
    Davidsen, Charlotte Kampp
    Baker, Ross A.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 65S - 65S
  • [5] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Anxiety Symptoms: An Exploratory Study
    Davis, Lori L.
    Ota, Ai
    Perry, Pamela
    Tsuneyoshi, Kana
    Weiller, Emmanuelle
    Baker, Ross
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 66S - 66S
  • [6] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Sleep Disturbances: An Exploratory Study
    Krystal, Andrew
    Mittoux, Aurelia
    Meisels, Peter
    Baker, Ross
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 64S - 65S
  • [7] Adjunctive brexpiprazole (OPC-34712) in patients with major depressive disorder and anxiety symptoms: an exploratory study
    Davis, Lori
    Ota, Ai
    Perry, Pamela
    Tsuneyoshi, Kana
    Weiller, Emmanuelle
    Baker, Ross
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 101 - 102
  • [8] EFFICACY OF BREXPIPRAZOLE (OPC-34712) IN ACUTE SCHIZOPHRENIA: RESULTS OF TWO POOLED PIVOTAL STUDIES
    Skuban, Aleksandar
    Correll, Christoph Ulrich
    Kane, John M.
    Ouyang, John
    Weiss, Catherine
    Weiller, Emmanuelle
    [J]. SCHIZOPHRENIA BULLETIN, 2015, 41 : S333 - S334
  • [9] EFFICACY AND SAFETY OF ADJUNCTIVE BREXPIPRAZOLE (OPC-34712) IN MAJOR DEPRESSIVE DISORDER (MDD): A PHASE III, RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Thase, M. E.
    Hobart, M.
    Augustine, C.
    Youakim, J.
    Zhang, P.
    Hefting, N.
    McQuade, R. D.
    Carson, W.
    Nyilas, M.
    Sanchez, R.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29
  • [10] Adjunctive Brexpiprazole (OPC-34712) in Patients with Major Depressive Disorder and Irritability: A Post-Hoc Analysis on Symptoms of Anger
    Menard, Francois
    Davidsen, Charlotte Kampp
    Weiller, Emmanuelle
    Baker, Ross A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S175 - S176
12345